Navigation Links
U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
Date:4/3/2008

DALLAS and REYKJAVIK, Iceland, April 3, 2008 /PRNewswire/ -- U.S. Preventive Medicine(R), (http://www.USPreventiveMedicine.com) the leader in prevention, and deCODE Genetics, the global leader in gene discovery, today announced they have signed a letter of intent to add genetic testing to expand both companies' personalized medicine services in the U.S. and internationally.

"The signing of the letter of intent with deCODE is significant because we will be the first entity in the U.S. and internationally to offer a full continuum of geographically dispersed, comprehensive solutions for personalized medicine including preventive care, wellness and disease management," said Christopher Fey, Chairman and CEO of U.S. Preventive Medicine. "We are very excited because our consumer, employer and physician customers will now be able to take advantage of a wide range of innovative personalized medicine services, including an opt-in genetic testing program for clients of our Centers for Preventive Medicine and members of The Prevention Plan. Our goal is to make the most advanced prevention strategies -- including more precise risk stratification -- available to informed consumers who want to use the best medicine has to offer to enjoy more good years."

Fey said U.S. Preventive Medicine's expansion into personalized medicine is the next step in the company's plan to provide practical solutions at every point in the healthcare continuum both nationally and internationally.

"The relationship with U.S. Preventive Medicine will offer us another platform to provide our genetic testing and personal genetics services through an innovative business model encompassing Centers for Preventive Medicine, as well as its new Prevention Plan health benefits," says Kari Stefansson, M.D., CEO of deCODE. "This partnership gives deCODE access to an even wider distribution channel of consumers, employers and
'/>"/>

SOURCE U.S. Preventive Medicine, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. U.S. Preventive Medicine National Policy Advisor Gov. Tommy Thompson to Propose Prevention is the Solution at UBS Global Health Services Conference
2. Protherics UK Ltd. Chooses TrackWise for Corrective Action and Preventive Action (CAPA) Management
3. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference
4. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
5. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
6. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
7. Partnership With SearchMedica.com to Enhance Web Searches on ModernMedicine.com
8. Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
9. Center for Molecular Medicine Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer
10. Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
11. Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Ambassador to also Visit Detroit , ... ,Who: David Appia, French Ambassador for Internat...st in France Agency, , , , ,What: Ambassador Appi...t pro-business initiatives adopted by France to fu...andscape for innovation and development., , ,When:...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Sigma-AldrichCorporat...nferenceonTuesday,December1stat1:45PMGMTinLondon,7...broadcastovertheInternetavailableat http://inve ...e"Webcast"icontoaccessthisfile. ,, AboutSigma...ghTechnologycompany.Itschemicalandbiochemicalprodu...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedth...approvedthe,investigationalnewdrugapplication(IND)...linformulationtotreatdiabetes.ThisIND,approvalallo..., Diabetesisadisordercharacteristicofhighbloodg...softenresultinseveremicro-and,macro-vasculardiseas...
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,N...company,today,announcedthatithassubmittedaMAAtothe...mpany,senzymereplacementtherapyindevelopment,forth...eting,applicationforvelaglucerasealfathathasbeensu...ndCanada. , Basedonaglobalsupplyshortageofthe...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...rican Academy of Ophthalmology,(AAO) 2008 Annual M...of,premium nutraceuticals for eye health, today an...y supplement to support the visual and overall,hea... -- 8% of the population and nearly 25% of those 6...n added to the 57 million,Americans with pre-diabe...
...Under Consideration, ROCKVILLE, Md., Nov. 10 Ent...rmaceutical company developing,therapeutics for th...oday,announced that it has met the primary endpoin... 1/2 study of MKC-1 in combination with pemetrexed...s., (Logo: http://www.newscom.com/cgi-bin/prnh/2...
...Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group...r of branded generic,pharmaceuticals and innovativ...ng China market, announced today its participation...mit 2008. The conference will be held at,the Manda...Simcere,s chief financial officer, Frank Zhigang Z...
Other Biology Technology:ScienceBased Health Announces the Launch of Diavis(TM), a New Dietary Supplement for the 81 Million Americans With or at Risk for Diabetes 2EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 2EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 3Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008 2
(Date:11/24/2009)...named 12 new grant recipients for 2009. The awards... across a broad spectrum of lupus research. All we...ential to drive scientific discovery to ultimately...ystemic lupus. , The 2009 grants go to both new ...n and include interdisciplinary and highly promisi...
(Date:11/24/2009)...lass of ring-shaped protein motors has been uncove...onal Laboratory (Berkeley Lab) using a state-of-th...nced Light Source (ALS). These protein motors play... and are vital to the survival of all biological c...man papillomavirus, which has been linked to cervi...
(Date:11/24/2009)...f debate. A high-profile study a few years ago sug...rbon from trees and leaves, evidence for a very cl...stems. , But new research from the University of...lgae provide a much richer diet for fish and other...s week in the Proceedings of the National Academy...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method 13471 1The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method 13471 2The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method 13471 3Predictors of disease behavior change in Crohn 26 23146 3Bs disease 54046 1STAT3 gene regulates cancer stem cells in brain cancer 9525 1STAT3 gene regulates cancer stem cells in brain cancer 9525 2
...s, using data from the agency,s AURA satellite, de...er Antarctica this year is smaller than in previou... thickness of the ozone layer was the first based ...nt on the agency,s Aura spacecraft. Aura was launc...4 million square miles at its peak between Septemb...
... rate of life-threatening adverse reactions to the...responders to a bioterrorism incident, possibly at...d educational programs, according to a study in th...munization against smallpox in the United States c... in the article. Although the World Health Organiz...
...nd imaging technology, which can spot cracks in sp...sealed envelope and detect tumors without harmful ...the national meeting of the American Chemical Soci...perts Charles A. Schmuttenmaer , professor of ch...d director of the Center for Terahertz Research at...
Other Biology News:NASA's AURA satellite peers into Earth's ozone hole 2Serious adverse reactions to smallpox vaccine appear to be limited 2T-rays: New imaging technology spotlighted by American Chemical Society 2
Chicken Anti-Human PFM8 Polyclonal Antibody, Unconjugated from ProSci, Inc
Rabbit Anti-NCoR2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-PITPN Antibody, Unconjugated from Raybiotech, Inc.
Goat Anti-Human Nebraska Calf Diarrhea Virus Polyclonal Antibody, FITC Conjugated from Abcam
Biology Products: